Fate Therapeutics, Inc.

Home » Fate Therapeutics, Inc.

Secondary

Fate Therapeutics, Inc.

Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders.

Symbol

FATE

Last Closing Price
$4.43

Shares
7,100,000

Effective Date
December 13, 2017

Underwriters
Leerink Partners, Piper Jaffray

To view the prospectus for Fate Therapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253